Dividend compounder review

CAI

Caris Life Sciences, Inc. Common Stock · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score35.50/100
Confidence68.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 15.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-68.1M
Free Cash Flow$66.9M
FCF Covers DividendUnknown
Debt / Equity0.73
P/E137.2
Revenue Growth 5Y14.3%
Net Margin3.7%
ROE28.4%
Price vs Trend-15.9%
3Y Return-
5Y Return-
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Less than five years of weekly price history available.
Dividend diary

Activity record

CAI dividend review warning Warning · Warning

Less than five years of weekly price history available.